Pegylated Irinotecan
IRB-30982
Phase 2 small_molecule completed
Quick answer
Pegylated Irinotecan for Stage IV Non-small Cell Lung Cancer (NSCLC) is a Phase 2 program (small_molecule) at NEKTAR THERAPEUTICS with 1 ClinicalTrials.gov record(s).
Program details
- Company
- NEKTAR THERAPEUTICS
- Indication
- Stage IV Non-small Cell Lung Cancer (NSCLC)
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- completed